Latest News
Dosing of First Patient in a Trial for LSALT Peptide is Sending Shares HIgher
AllPennyStocks.com - Mon Nov 11, 2:04PM CST
AllPennyStocks.com
Mon Nov 11, 2:04PM CST
This late-stage clinical trial company focuses on preventing inflammation and acute organ injury. It is developing a platform of new drugs to prevent inflammation in the kidneys, liver and lungs via the dipeptidase-1 (DPEP1) pathway, addressing common injuries and diseases where organ inflammation remains an unmet need. And now, they...
Arch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
GlobeNewswire - Mon Nov 11, 6:30AM CST
GlobeNewswire
Mon Nov 11, 6:30AM CST
Arch Biopartners: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ARCH)
AI-generated - The Globe and Mail - Tue Oct 29, 8:06PM CDT
AI-generated - The Globe and Mail
Tue Oct 29, 8:06PM CDT
Arch Biopartners is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation โ a calculation used to determine the intrinsic (true) worth of a company Valuation methodology provided...
Arch Biopartners Arranges Non-Brokered Private Placement
GlobeNewswire - Tue Oct 15, 5:23PM CDT
GlobeNewswire
Tue Oct 15, 5:23PM CDT
Closes Units for Debt Settlement
GlobeNewswire - Thu Oct 3, 6:45AM CDT
GlobeNewswire
Thu Oct 3, 6:45AM CDT
Arch Biopartners: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ARCH)
AI-generated - The Globe and Mail - Tue Oct 1, 8:53PM CDT
AI-generated - The Globe and Mail
Tue Oct 1, 8:53PM CDT
Arch Biopartners is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation โ a calculation used to determine the intrinsic (true) worth of a company Valuation methodology provided...
Units for Debt Settlement
GlobeNewswire - Thu Sep 26, 7:46AM CDT
GlobeNewswire
Thu Sep 26, 7:46AM CDT
Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
GlobeNewswire - Wed Sep 11, 5:30AM CDT
GlobeNewswire
Wed Sep 11, 5:30AM CDT
Closing Bell: Arch Biopartners Inc down on Wednesday (ARCH)
Automated Summaries - The Globe and Mail - Wed Aug 7, 4:02PM CDT
Automated Summaries - The Globe and Mail
Wed Aug 7, 4:02PM CDT
Closing Bell: Arch Biopartners Inc down on Tuesday (ARCH)
Automated Summaries - The Globe and Mail - Tue Aug 6, 4:02PM CDT
Automated Summaries - The Globe and Mail
Tue Aug 6, 4:02PM CDT
Closing Bell: Arch Biopartners Inc up on Friday (ARCH)
Automated Summaries - The Globe and Mail - Mon Aug 5, 4:02PM CDT
Automated Summaries - The Globe and Mail
Mon Aug 5, 4:02PM CDT
Closing Bell: Arch Biopartners Inc up on Friday (ARCH)
Automated Summaries - The Globe and Mail - Fri Aug 2, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Aug 2, 4:01PM CDT
Arch Biopartnersโ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
GlobeNewswire - Fri Aug 2, 6:20AM CDT
GlobeNewswire
Fri Aug 2, 6:20AM CDT
Closing Bell: Arch Biopartners Inc up on Thursday (ARCH)
Automated Summaries - The Globe and Mail - Thu Aug 1, 4:01PM CDT
Automated Summaries - The Globe and Mail
Thu Aug 1, 4:01PM CDT
Closing Bell: Arch Biopartners Inc down on Wednesday (ARCH)
Automated Summaries - The Globe and Mail - Wed Jul 31, 4:02PM CDT
Automated Summaries - The Globe and Mail
Wed Jul 31, 4:02PM CDT
Closing Bell: Arch Biopartners Inc up on Tuesday (ARCH)
Automated Summaries - The Globe and Mail - Tue Jul 30, 4:02PM CDT
Automated Summaries - The Globe and Mail
Tue Jul 30, 4:02PM CDT
Arch Biopartners Closes Non-Brokered Private Placement
GlobeNewswire - Tue Jul 30, 3:47PM CDT
GlobeNewswire
Tue Jul 30, 3:47PM CDT
Closing Bell: Arch Biopartners Inc down on Monday (ARCH)
Automated Summaries - The Globe and Mail - Mon Jul 29, 4:02PM CDT
Automated Summaries - The Globe and Mail
Mon Jul 29, 4:02PM CDT
Arch Biopartners Arranges Non-Brokered Private Placement
GlobeNewswire - Mon Jul 29, 3:52PM CDT
GlobeNewswire
Mon Jul 29, 3:52PM CDT
Closing Bell: Arch Biopartners Inc up on Friday (ARCH)
Automated Summaries - The Globe and Mail - Fri Jul 26, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Jul 26, 4:01PM CDT
Closing Bell: Arch Biopartners Inc down on Thursday (ARCH)
Automated Summaries - The Globe and Mail - Thu Jul 25, 4:01PM CDT
Automated Summaries - The Globe and Mail
Thu Jul 25, 4:01PM CDT
Closing Bell: Arch Biopartners Inc up on Wednesday (ARCH)
Automated Summaries - The Globe and Mail - Wed Jul 24, 4:02PM CDT
Automated Summaries - The Globe and Mail
Wed Jul 24, 4:02PM CDT
Closing Bell: Arch Biopartners Inc down on Tuesday (ARCH)
Automated Summaries - The Globe and Mail - Tue Jul 23, 4:02PM CDT
Automated Summaries - The Globe and Mail
Tue Jul 23, 4:02PM CDT
Closing Bell: Arch Biopartners Inc down on Monday (ARCH)
Automated Summaries - The Globe and Mail - Mon Jul 22, 4:02PM CDT
Automated Summaries - The Globe and Mail
Mon Jul 22, 4:02PM CDT
Closing Bell: Arch Biopartners Inc up on Friday (ARCH)
Automated Summaries - The Globe and Mail - Fri Jul 19, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Jul 19, 4:01PM CDT